Nicosia Biolabs International Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 M
- Revenue Growth 180.42%
- Profit Growth 508.23%
- Ebitda 84.54%
- Net Worth 128.53%
- Total Assets 28.16%
About Nicosia Biolabs International
Nicosia Biolabs International Private Limited (NBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2021 (Three years and six months 18 days old ). Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.00 M.
Gaurav Sahni and Harish Sahni serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230PB2021PTC053915
-
Company No.
053915
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jul 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Nicosia Biolabs International Private Limited offer?
Nicosia Biolabs International Private Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Disinfectant Spray, Animal Medicines & Health Care, Veterinary Medicines, Veterinary Injections, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Nicosia Biolabs International?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gaurav Sahni
![]() |
Managing Director | 28-Jul-2021 | Current |
Harish Sahni
![]() |
Managing Director | 28-Jul-2021 | Current |
Board Members
![People](/Images/tcc-no-data-images/people-and-contacts.webp)
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Nicosia Biolabs International.
Nicosia Biolabs International Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 180.42% increase. The company also saw a substantial improvement in profitability, with a 508.23% increase in profit. The company's net worth Soared by an impressive increase of 128.53%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Nicosia Biolabs International?
Unlock access to Nicosia Biolabs International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹7.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.70 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
03 Mar 2022 | Others | ₹7.00 M | Open |
How Many Employees Work at Nicosia Biolabs International?
Unlock and access historical data on people associated with Nicosia Biolabs International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Nicosia Biolabs International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nicosia Biolabs International's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.